Specialist touts vaccines as Merck antiviral pill moves to U.S. regulators

Merck's new antiviral pill for COVID-19 may be of some help once it is approved by health regulators, says Montreal cardiologist Dr. Christopher Labos, but he's wary of the term 'game changer.' (Merck & Co.)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting